2.33

3.72% -0.09

Maravai Lifesciences Holdings Inc (MRVI)

Overview News Price History Option Chain Financials Why MRVI Down? Discussions Forecast

Maravai Lifesciences Holdings Inc stock is traded at $2.33, with a volume of 1.04M. It is down -3.72% in the last 24 hours and down -13.38% over the past month. Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

Previous Close:

$2.42

Open:

$2.42

24h Volume:

1.04M

Relative Volume:

0.64

Market Cap:

$337.10M

Revenue:

$288.95M

Net Income/Loss:

$-119.03M

P/E Ratio:

-2.5875

EPS:

-0.9005

Net Cash Flow:

$60.67M

1W Performance:

-5.28%

1M Performance:

-13.38%

6M Performance:

-23.61%

1Y Performance:

-74.20%

1-Day Range:

$2.28

$2.47

1-Week Range:

$2.28

$2.505

52-Week Range:

$1.665

$9.60

Maravai Lifesciences Holdings Inc Stock (MRVI) Company Profile

Name

Maravai Lifesciences Holdings Inc

Sector

Healthcare (1146)

Industry

Biotechnology (644)

Phone

(858) 546-0004

Address

10770 WATERIDGE CIRCLE SUITE 200, SAN DIEGO

Employee

560

Twitter

Next Earnings Date

2025-03-18

Latest SEC Filings

MRVI's Discussions on Twitter

Compare MRVI with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
MRVI Maravai Lifesciences Holdings Inc	2.33	350.12M	288.95M	-119.03M	60.67M	-0.9005
VRTX Vertex Pharmaceuticals Inc	389.08	99.27B	11.39B	3.64B	3.50B	13.99
REGN Regeneron Pharmaceuticals Inc	586.96	62.28B	14.21B	4.46B	3.56B	39.68
ALNY Alnylam Pharmaceuticals Inc	454.18	59.14B	2.46B	-319.09M	-52.09M	-2.47
ARGX Argen X Se Adr	707.96	43.34B	3.06B	1.28B	447.35M	21.30
ONC Beone Medicines Ltd Adr	300.14	36.72B	3.81B	-644.79M	-669.77M	-6.24

Maravai Lifesciences Holdings Inc Stock (MRVI) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-26-25	Downgrade	Robert W. Baird	Outperform → Neutral
Dec-19-24	Initiated	Guggenheim	Neutral
Dec-05-24	Downgrade	Goldman	Neutral → Sell
Nov-14-24	Initiated	Wolfe Research	Peer Perform
Nov-08-24	Downgrade	William Blair	Outperform → Mkt Perform
Aug-28-24	Initiated	Wells Fargo	Overweight
Aug-13-24	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Apr-10-24	Initiated	Craig Hallum	Buy
Dec-12-23	Upgrade	BofA Securities	Neutral → Buy
Aug-08-23	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
May-23-23	Downgrade	Credit Suisse	Outperform → Neutral
May-09-23	Downgrade	Goldman	Buy → Neutral
Jan-05-23	Downgrade	UBS	Buy → Neutral
Dec-14-22	Initiated	Deutsche Bank	Buy
Dec-07-22	Initiated	RBC Capital Mkts	Outperform
Nov-03-22	Downgrade	BofA Securities	Buy → Neutral
Aug-25-22	Initiated	Credit Suisse	Outperform
Aug-05-21	Resumed	Credit Suisse	Outperform
Dec-16-20	Initiated	KeyBanc Capital Markets	Overweight
Dec-15-20	Initiated	BofA Securities	Buy
Dec-15-20	Initiated	Credit Suisse	Outperform
Dec-15-20	Initiated	Goldman	Buy
Dec-15-20	Initiated	Jefferies	Buy
Dec-15-20	Initiated	Robert W. Baird	Outperform
Dec-15-20	Initiated	Stifel	Buy
Dec-15-20	Initiated	William Blair	Outperform
Dec-14-20	Initiated	UBS	Buy

View All

Maravai Lifesciences Holdings Inc Stock (MRVI) Latest News

02:34 AM

Will Maravai LifeSciences Holdings Inc. price bounce be sustainableJuly 2025 Setups & Expert-Curated Trade Recommendations - Newser

02:34 AM

Aug 27, 2025

Will Maravai LifeSciences Holdings Inc. stock recover after recent dropWeekly Trend Recap & Step-by-Step Swing Trade Plans - Newser

Aug 27, 2025

Published on: 2025-08-27 21:15:20 - Newser

Aug 27, 2025

Is Maravai LifeSciences Holdings Inc. meeting your algorithmic filter criteria2025 Investor Takeaways & Community Consensus Trade Signals - Newser

Aug 27, 2025

Price momentum metrics for Maravai LifeSciences Holdings Inc. explainedInsider Selling & High Yield Stock Recommendations - Newser

Aug 27, 2025

Published on: 2025-08-27 14:13:32 - Newser

Aug 27, 2025

What makes enGene Holdings Inc. stock price move sharply - Newser

Aug 27, 2025

Building trade automation scripts for Maravai LifeSciences Holdings Inc.Earnings Beat & Low Drawdown Investment Strategies - Newser

Aug 27, 2025

Maravai LifeSciences Holdings Inc. stock trend outlook and recovery pathTrade Risk Assessment & Growth Focused Entry Point Reports - Newser

Aug 27, 2025

Will Maravai LifeSciences Holdings Inc. see short term momentum2025 Technical Patterns & Precise Buy Zone Identification - Newser

Aug 27, 2025

Short interest data insights for Maravai LifeSciences Holdings Inc.Weekly Earnings Recap & Real-Time Stock Price Movement Reports - Newser

Aug 27, 2025

Maravai LifeSciences Holdings Inc. stock daily chart insightsWeekly Trade Report & Long-Term Growth Stock Strategies - Newser

Aug 27, 2025

Earnings visualization tools for Maravai LifeSciences Holdings Inc.Market Performance Summary & Accurate Intraday Trading Signals - Newser

Aug 27, 2025

Should you hold or exit Maravai LifeSciences Holdings Inc. nowPortfolio Gains Report & Step-by-Step Trade Execution Guides - Newser

Aug 27, 2025

Aug 26, 2025

Risk adjusted return profile for Maravai LifeSciences Holdings Inc. analyzedQuarterly Market Review & Consistent Profit Trading Strategies - Newser

Aug 26, 2025

How to forecast Maravai LifeSciences Holdings Inc. trends using time seriesJuly 2025 Weekly Recap & Real-Time Chart Pattern Alerts - Newser

Aug 26, 2025